Cyclerion Therapeutics Inc (CYCN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2021 | 12-2020 | 09-2020 | 06-2020 | 03-2020 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -13,399 | -77,802 | -58,574 | -39,762 | -20,228 |
| Depreciation Amortization | 258 | 2,297 | 1,827 | 1,239 | 626 |
| Accounts receivable | 127 | 1,346 | 1,074 | 723 | 448 |
| Accounts payable and accrued liabilities | -340 | -1,096 | -680 | 48 | -1,048 |
| Other Working Capital | -3,614 | -7,592 | -9,148 | -10,948 | -11,460 |
| Other Operating Activity | 2,513 | 10,357 | 7,052 | 5,299 | 2,482 |
| Operating Cash Flow | $-14,455 | $-72,490 | $-58,449 | $-43,401 | $-29,180 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | 1,462 | 18 | -1,418 | -1,421 | -1,356 |
| Investing Cash Flow | $1,462 | $18 | $-1,418 | $-1,421 | $-1,356 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | N/A | 3,509 | 3,509 | 3,509 | N/A |
| Common Stock Issued | 27 | 331 | 172 | 155 | 1 |
| Other Financing Activity | 0 | 24,250 | 24,250 | 0 | 0 |
| Financing Cash Flow | $27 | $28,090 | $27,931 | $3,664 | $1 |
| Exchange Rate Effect | N/A | -7 | -7 | -10 | 2 |
| Beginning Cash Position | 58,232 | 102,621 | 102,620 | 102,621 | 102,620 |
| End Cash Position | 45,266 | 58,232 | 70,677 | 61,453 | 72,087 |
| Net Cash Flow | $-12,966 | $-44,389 | $-31,943 | $-41,168 | $-30,533 |
| Free Cash Flow | |||||
| Operating Cash Flow | -14,455 | -72,490 | -58,449 | -43,401 | -29,180 |
| Capital Expenditure | N/A | -1,524 | -1,489 | -1,480 | -1,405 |
| Free Cash Flow | -14,455 | -74,014 | -59,938 | -44,881 | -30,585 |